CTRI/2019/04/018778已完成4 期
A Randomized Controlled Clinical Study on the efficacy of Guda-Haritaki in Kaphaja Pratishaya with special reference to Allergic Rhinitis in children
Dattatray Chavan0 个研究点目标入组 197 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 197
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Children are with symptoms of Kaphaja Pratishaya (Allergic Rhinitis) of age 6 to 12 years1.
- •Patients will be selected irrespective of sex and religion.
- •Patients, whose parents are willing to participate their child in the study and
- •are ready to sign informed consent form will be selected for the study.
- •Children with symptoms of Allergic Rhinitis occur for > 4 days per week and / or for > 4 consecutive weeks at a time.
- •The laboratory finding of increased numbers of eosinophils in the nasal mucosal smear (presence of > 4 % eosinophils for 6 to 10 years of age and >10 % eosinophils for 11 to 12 years of age) and elevated Total Serum IgE concentration ( > 20 IU/ml)that patients will be selected.
排除标准
- •Patients with nasal abnormalities like D.N.S., Nasal polyps, adenoid and tonsilar hypertrophy.
- •Patients with acute respiratory infection or severe concomitant disease (Tuberculosis, Pneumonia).
- •Malnourished child.
研究者
相似试验
尚未招募
2 期
Effect of Nagaradi Gutika and Shirodhara with Medhya Kashaya Taila in the management of Insomnia in Elderly.CTRI/2021/03/032050Banaras Hindu University
尚未招募
3 期
A Clinical trial to study the effect of Aswagandha Taila Matra Basti in patients with Nashtabeeja (Anovulation)CTRI/2023/06/053698Drishya Jyothirmayan
招募中
不适用
A randomized controlled clinical study on the effect of moxibustion on the quality of life in patients with gastric cancergastric cancerITMCTR2000004191Hebei University of Chinese Meidicne
尚未招募
2 期
Clinical Study Of Efficacy Of Vaishvanara Churna In The Managment Of Vibandha With Reference To Fuctional Constipation In ChildreCTRI/2024/05/066821Dr. Ajinkya Vilasrao Peshattiwar
进行中(未招募)
不适用
RANDOMIZED CONTROLLED CLINICAL STUDY ON THE EFFICACY AND TOLERABILITY OF 0.4% HYALURONIC ACID HYPOTONIC EYE DROPS (IALUREX) VS. HYDROXYPROPYL-GUAR EYE DROPS (SYSTANE) IN THE TREATMENT OF DRY EYE SYNDROME - NDDry eye syndromeMedDRA version: 9.1Level: LLTClassification code 10023350Term: Keratoconjunctivitis siccaEUCTR2007-005882-37-ITBAUSCH&LOMB
